Xavier Matias-Guiu Guia
Grado: Doctor/a
973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: http://www.researcherid.com/rid/C-3039-2009
Grupos
Publicaciones
-
Capella, G; MATIASGUIU, X; Ampudia, X; deLeiva, A; Perucho, M; Prat, J
Ras oncogene mutations in thyroid tumors - Polymerase chain reaction-restriction-fragment-length polymorphism analysis from paraffin-embedded tissues
Diagnostic Molecular Pathology 5 45-52. .
-
Chico, A; Pallares, MC; MATIASGUIU, X; Cipres, L; PuigDomingo, M; Webb, SM
Bronchial carcinoid tumor presenting as a thyroid nodule: an unusual clinical manifestation
Journal Of Endocrinological Investigation 19 186-189. .
-
Sole, JM; Guedea, F; MATIASGUIU, X; Lerma, E; Seral, A
Long-term risk of sarcoma following radiation treatment for breast cancer
ONCOL REP 3 397-399. .
-
Hidalgo, L; Villanueva, A; Soler, T; Guiu, XM; Capella, G
Molecular alterations in adenocarcinoma of small bowel associated with Peutz-Jeghers syndrome.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS 88 137-140. .
-
Colomer, A; MartinezMas, JV; MATIASGUIU, X; Llorens, A; Cabezas, R; Prat, J; GarciaAmeijeiras, A
Sex-steroid hormone receptors in human medullary thyroid carcinoma
Modern Pathology 9 68-72. .
-
Alejo, M; Margall, N; MATIASGUIU, X; Esteva, E; Lerma, E; Coll, P; Prat, J
DNa-ploidy and HPV infection in epithelial lesions of the lower female genital tract
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 6 1-7. .
-
Komminoth, P; MulettaFeurer, S; Saremaslani, P; Seelentag, WKF; Kunz, EK; Hiort, O; MATIASGUIU, X; Roth, J; Heitz, PU
RET proto-oncogene point mutations in sporadic neuroendocrine tumors
LABORATORY INVESTIGATION 74 270-270. .
-
Costa, I; Colomer, A; Lerma, E; MATIASGUIU, X; Prat, J
Prognostic factors in stage I ovarian cancer
LABORATORY INVESTIGATION 74 509-509. .
-
MATIASGUIU, X
Biotin-rich nuclear inclusions of gestational endometrium, not herpes infection
PATHOL RES PRACT 191 1271-1272. .
-
CAIXAS, A; BERNA, L; PIERA, J; RIGLA, M; MATIASGUIU, X; FARRERONS, J; PUIGDOMINGO, M
UTILITY OF TC-99M-SESTaMIBI SCINTIGRaPHY aS a FIRST-LINE IMaGING PROCEDURE IN THE PREOPERaTIVE EVaLUaTION OF HYPERPaRaTHYROIDISM
CLINICAL ENDOCRINOLOGY 43 525-530. .
-
KOMMINOTH, P; MULETTAFEURER, S; SAREMASLANI, P; KUNZ, EK; MATIASGUIU, X; HIORT, O; SCHRODER, S; SEELENTAG, WKF; ROTH, J; HEITZ, PU
MOLECULaR DIaGNOSIS OF MULTIPLE ENDOCRINE NEOPLaSIa (MEN) IN PaRaFFIN-EMBEDDED SPECIMENS
ENDOCRINE PATHOLOGY 6 267-278. .
-
CHICO, A; GARCIA, JL; MATIASGUIU, X; WEBB, SM; RODRIGUEZ, J; PRAT, J; CALAF, J
A GONaDOTROPIN DEPENDENT STROMaL LUTEOMa - a RaRE CaUSE OF POSTMENOPaUSaL VIRILIZaTION
CLINICAL ENDOCRINOLOGY 43 645-649. .
Proyectos
- Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
- Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
- EPH Receptor Signaling in Endometrial Cancer
- Ajuts per a la contractació de personal investigador novell (FI)
- Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
- "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
- EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
- Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
- CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
- DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
- Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
- VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
